Publications

Detailed Information

Quantitative electroencephalographic (qEEG) correlates of craving during virtual reality therapy in alcohol-dependent patients

DC Field Value Language
dc.contributor.authorLee, Sang Hoon-
dc.contributor.authorHan, Doug Hyun-
dc.contributor.authorOh, Seman-
dc.contributor.authorLyoo, In Iyoon-
dc.contributor.authorRenshaw, Perry F.-
dc.contributor.authorLukas, Scott E.-
dc.contributor.authorLee, Young Sik-
dc.date.accessioned2012-07-05T01:06:37Z-
dc.date.available2012-07-05T01:06:37Z-
dc.date.issued2009-01-
dc.identifier.citationPHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR; Vol.91(3); 393-397ko_KR
dc.identifier.issn0091-3057-
dc.identifier.urihttps://hdl.handle.net/10371/78533-
dc.description.abstractVirtual reality (VR) is an evolving technology that is being applied to treat a wide range of medical and psychiatric diseases. A virtual reality therapy (VRT) with multisensory stimulation has been applied to patients with alcohol dependence (ADP). We hypothesized that the VRTP for alcohol dependence would reduce the craving for alcohol and increase alpha wave activity in frontal areas of individuals with ADP. Twenty ADP and eighteen AN were exposed to a series of 10 VRTP sessions (VRTP-ADP) and cognitive behavioral therapy (nVRTP-ADP), respectively. Fifteen healthy controls were exposed to VRTP for comparing the changes of craving and EEG during all three phases of VRTP. The VRTP-ADP exhibited a greater decrease in craving after the 10th VRTP session, when compared to the nVRTP-ADP. Compared to the healthy control subjects, VRTP-ADP group showed higher magnitude of the change in craving throughout VRTP sessions. These results suggest that VRTP may be useful as an adjunct to treating alcohol dependence but may also serve as an evaluation tool to identify high-risk patients.ko_KR
dc.language.isoenko_KR
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDko_KR
dc.subjectVirtual realityko_KR
dc.subjectCravingko_KR
dc.subjectEEGko_KR
dc.subjectFrontal cortexko_KR
dc.subjectAlcohol dependenceko_KR
dc.titleQuantitative electroencephalographic (qEEG) correlates of craving during virtual reality therapy in alcohol-dependent patientsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이상훈-
dc.contributor.AlternativeAuthor한덕현-
dc.contributor.AlternativeAuthor오세만-
dc.contributor.AlternativeAuthor류인륜-
dc.contributor.AlternativeAuthor이영식-
dc.identifier.doi10.1016/j.pbb.2008.08.014-
dc.citation.journaltitlePHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR-
dc.description.citedreferenceYong NA, 2007, J NEUROPHYSIOL, V97, P1100, DOI 10.1152/jn.00694.2006-
dc.description.citedreferenceMihai A, 2007, ADDICTION, V102, P226, DOI 10.1111/j.1360-0443.2006.01667.x-
dc.description.citedreferenceBaumann SB, 2006, PSYCHOL ADDICT BEHAV, V20, P484, DOI 10.1037/0893-164X.20.4.484-
dc.description.citedreferenceViaud-Delmon I, 2006, EUR PSYCHIAT, V21, P501, DOI 10.1016/j.eurpsy.2004.10.004-
dc.description.citedreferenceLee E, 2006, YONSEI MED J, V47, P491-
dc.description.citedreferenceLee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z-
dc.description.citedreferenceAnderson PL, 2005, DEPRESS ANXIETY, V22, P156, DOI 10.1002/da.20090-
dc.description.citedreferenceMyrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295-
dc.description.citedreferenceKLINGER E, 2004, ST HEAL T, V99, P91-
dc.description.citedreferenceKim DJ, 2003, ALCOHOL CLIN EXP RES, V27, P1955, DOI 10.1097/01.ALC.0000100943.83959.1F-
dc.description.citedreferenceLambrey S, 2003, INT J PSYCHOPHYSIOL, V50, P101, DOI 10.1016/S0167-8760(03)00127-2-
dc.description.citedreferenceJang DP, 2002, IEEE T INF TECHNOL B, V6, P213, DOI 10.1109/TITB.2002.802374-
dc.description.citedreferenceCosman PH, 2002, ANZ J SURG, V72, P30-
dc.description.citedreferenceRothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617-
dc.description.citedreferenceSchneider F, 2001, AM J PSYCHIAT, V158, P1075-
dc.description.citedreferenceGeorge MS, 2001, ARCH GEN PSYCHIAT, V58, P345-
dc.description.citedreferenceBechara A, 2000, CEREB CORTEX, V10, P295-
dc.description.citedreferenceSchultz W, 2000, CEREB CORTEX, V10, P272-
dc.description.citedreferenceRolls ET, 2000, CEREB CORTEX, V10, P284-
dc.description.citedreferenceStacy AW, 1998, EXP CLIN PSYCHOPHARM, V6, P280-
dc.description.citedreferenceLiu X, 1998, NEUROPSYCHOPHARMACOL, V19, P10-
dc.description.citedreferenceNORTH MM, 1998, ST HEAL T, V58, P112-
dc.description.citedreferenceAnton RF, 1996, ALCOHOL CLIN EXP RES, V20, pA3-
dc.description.citedreferenceBURDEA G, 1996, FORCE TOUCH FEEDBACK-
dc.description.citedreferenceMODELL JG, 1995, J NEUROPSYCH CLIN N, V7, P15-
dc.description.citedreferenceLITTLETON J, 1995, ADDICTION, V90, P1179-
dc.description.citedreferenceLUKAS SE, 1995, DRUG ALCOHOL DEPEN, V37, P131-
dc.description.citedreferenceBAUER LO, 1994, BIOL PSYCHIAT, V36, P189-
dc.description.citedreferenceBURDEA G, 1994, VIRTUAL REALITY TECH-
dc.description.citedreferenceROBINSON TE, 1993, BRAIN RES REV, V18, P247-
dc.description.citedreferenceVOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876-
dc.description.citedreferenceELKINS RL, 1991, BEHAV RES THER, V29, P387-
dc.description.citedreferenceLUKAS SE, 1990, ALCOHOL, V7, P471-
dc.description.citedreferenceSMITH JW, 1990, J SUBST ABUSE TREAT, V7, P77-
dc.description.citedreferenceHOWARD MO, 1990, INT J ADDICT, V25, P1403-
dc.description.citedreferenceCHRISTIANSEN BA, 1989, J CONSULT CLIN PSYCH, V57, P93-
dc.description.citedreferenceWISE RA, 1988, J ABNORM PSYCHOL, V97, P118-
dc.description.citedreferenceLUKAS SE, 1988, BIOL PSYCHIAT, V23, P141-
dc.description.citedreferenceLUKAS SE, 1986, PHARMACOL BIOCHEM BE, V25, P889-
dc.description.citedreferenceLUDWIG AM, 1974, ARCH GEN PSYCHIAT, V30, P539-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share